Sunesis
1998
FOUNDED
PUBLIC
STATUS
31-40
EMPLOYEES
SNSS
STOCK SYMBOL
$2.29
SHARE PRICE
(As of Monday Closing)
Description
Developer of biopharmaceutical drugs designed to develop and commercialize new oncology therapeutics. The company's biopharmaceutical drug QINPREZO is the lead product candidate for the potential treatment of acute myeloid leukemia which contains Vosaroxin, an anticancer quinolone derivative, a class of compounds that has not been used previously for the treatment of cancer, enabling physicians to treat solid and hematologic cancers.
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Stock Exchange
NAS
Primary Office
- 395 Oyster Point Boulevard
- Suite 400
- South San Francisco, CA 94080
- United States
+1 (650) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Sunesis’s full profile, request a free trial.
Sunesis Stock Performance
| 52 wk Range | Market Cap | Prev. Close | EPS | Average Volume | Shares |
|---|---|---|---|---|---|
| $1.85 - $7.36 | $84.6M | $2.34 | -$0.99 | 217K | 36.1M |
Sunesis Financials Summary
|
In Thousands,
USD |
TTM
30-Jun-2018
|
FY 2017
31-Dec-2017
|
FY 2016
31-Dec-2016
|
FY 2015
31-Dec-2015
|
|---|---|---|---|---|
| Enterprise Value | 81,751 | 122,796 | 66,236 | 55,513 |
| Revenue | 237 | 669 | 2,536 | 3,061 |
| EBITDA | (29,750) | (34,053) | (36,291) | (35,710) |
| Net Income | (30,895) | (35,458) | (38,023) | (36,676) |
| Total Assets | 22,021 | 34,334 | 43,234 | 47,002 |
| Total Debt | 7,300 | 7,204 | 14,435 | 7,834 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Sunesis Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Sunesis‘s full profile, request access.
Request full access to PitchBookSunesis Investors
| Investor Name | Investor Type | Holding | Participating Rounds | Investor Since | Board Seat | Contact Info |
|---|
This information is reserved for PitchBook Platform users. To explore Sunesis‘s full profile, request access.
Request full access to PitchBookSunesis Executive Team (15)
6 Former Executives
You’re viewing 5 of 15 executives. Get the full list »Sunesis Board Members (11)
3 Former Board Members
You’re viewing 5 of 11 board members. Get the full list »